The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones
The global Anti-Viral Drugs market was valued at US$ 117610 million in 2023 and is anticipated to reach US$ 150280 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Viral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Viral Drugs.
Report Scope
The Anti-Viral Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Viral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Viral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Bristol-Myers-Squibb
- AbbVie
- Johnson & Johnson
- Merck & Co
- Aurobindo Pharma
- Cipla
- Dr Reddy’s
Segment by Type
- Nucleotide Polymerase Inhibitor
- Reverse Transcriptase Inhibitor
- Protease Inhibitor
Segment by Application
- HIV
- Hepatitis
- HSV
- Influenza
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Viral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Viral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Anti-Viral Drugs Market Overview
1.1 Product Overview and Scope of Anti-Viral Drugs
1.2 Anti-Viral Drugs Segment by Type
1.2.1 Global Anti-Viral Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Nucleotide Polymerase Inhibitor
1.2.3 Reverse Transcriptase Inhibitor
1.2.4 Protease Inhibitor
1.3 Anti-Viral Drugs Segment by Application
1.3.1 Global Anti-Viral Drugs Market Value by Application: (2024-2030)
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 HSV
1.3.5 Influenza
1.4 Global Anti-Viral Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Viral Drugs Revenue 2019-2030
1.4.2 Global Anti-Viral Drugs Sales 2019-2030
1.4.3 Global Anti-Viral Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Viral Drugs Market Competition by Manufacturers
2.1 Global Anti-Viral Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Viral Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Viral Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Viral Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Viral Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Viral Drugs, Product Type & Application
2.7 Anti-Viral Drugs Market Competitive Situation and Trends
2.7.1 Anti-Viral Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Viral Drugs Players Market Share by Revenue
2.7.3 Global Anti-Viral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Viral Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Viral Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Viral Drugs Global Anti-Viral Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-Viral Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-Viral Drugs Sales by Region: 2025-2030
3.3 Global Anti-Viral Drugs Global Anti-Viral Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-Viral Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-Viral Drugs Revenue by Region: 2025-2030
3.4 North America Anti-Viral Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Viral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Viral Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-Viral Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Viral Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Viral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Viral Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-Viral Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Viral Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Viral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Viral Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Viral Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Viral Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Viral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Viral Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-Viral Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Viral Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Viral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Viral Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Viral Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Viral Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-Viral Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-Viral Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-Viral Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-Viral Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-Viral Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-Viral Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-Viral Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Viral Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Viral Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-Viral Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-Viral Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-Viral Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-Viral Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-Viral Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-Viral Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-Viral Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Viral Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Corporation Information
6.1.2 F. Hoffmann-La Roche Description and Business Overview
6.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolio
6.1.5 F. Hoffmann-La Roche Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Anti-Viral Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Bristol-Myers-Squibb
6.3.1 Bristol-Myers-Squibb Corporation Information
6.3.2 Bristol-Myers-Squibb Description and Business Overview
6.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolio
6.3.5 Bristol-Myers-Squibb Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AbbVie Anti-Viral Drugs Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Anti-Viral Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Merck & Co
6.6.1 Merck & Co Corporation Information
6.6.2 Merck & Co Description and Business Overview
6.6.3 Merck & Co Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck & Co Anti-Viral Drugs Product Portfolio
6.6.5 Merck & Co Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Anti-Viral Drugs Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cipla Anti-Viral Drugs Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Dr Reddy’s
6.9.1 Dr Reddy’s Corporation Information
6.9.2 Dr Reddy’s Description and Business Overview
6.9.3 Dr Reddy’s Anti-Viral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr Reddy’s Anti-Viral Drugs Product Portfolio
6.9.5 Dr Reddy’s Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Viral Drugs Industry Chain Analysis
7.2 Anti-Viral Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Viral Drugs Production Mode & Process
7.4 Anti-Viral Drugs Sales and Marketing
7.4.1 Anti-Viral Drugs Sales Channels
7.4.2 Anti-Viral Drugs Distributors
7.5 Anti-Viral Drugs Customers
8 Anti-Viral Drugs Market Dynamics
8.1 Anti-Viral Drugs Industry Trends
8.2 Anti-Viral Drugs Market Drivers
8.3 Anti-Viral Drugs Market Challenges
8.4 Anti-Viral Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
